ArticleCurrent issues in molecular biology2026
Zhuqiao Jiang, Lingmei Zhou, Jinping Wang, Hao Sun, Liwen Cai, Hanqi Yin, Hui Zhu, Ming Li, Zhuoya Wang
Abstract read
In one paragraphArticle in Current issues in molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Zhuqiao JiangGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Lingmei ZhouGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Jinping WangGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Hao SunGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Liwen CaiGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0009-0009-1172-2205 Hanqi YinSouth China Institute of Biomedicine, Guangzhou 510535, China.
Hui ZhuThe First Affiliated Hospital, Guangdong Pharmaceutical University, Guangzhou 510080, China.
Ming LiGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0001-9981-0270 Zhuoya WangGuangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, School of Basic Medical Sciences, Guangdong Pharmaceutical University, Guangzhou 510006, China.ORCID 0000-0003-3596-7337 Funding
National Natural Science Foundation of China 82004035Scientific Research Project of the Guangdong Provincial Bureau of Traditional Chinese Medicine 20251223
6 · The paper itselfAbstract
Invasive pulmonary aspergillosis (IPA) poses a serious threat to immunocompromised hosts, with limited therapeutic options highlighting the need for novel strategies.
Indexed as
complement activationCoptis chinensis Franch.invasive pulmonary aspergillosisNADPH oxidaseneutrophil extracellular traps
Identifiers
PMID42042084
PMCPMC13115011
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390